Pharmacokinetics of Hydroxyprogesterone Caproate and its Primary Metabolites during Pregnancy
Abstract Objective To measure pharmacokinetics of hydroxyprogesterone caproate (OHPC) and its major metabolites throughout pregnancy. Study Design Thirty women were prescribed OHPC for recurrent preterm birth prevention. Three cohorts of subjects had blood drawn for 7 conse...
Main Authors: | Kim A. Boggess, Jeffrey B. Baker, Amy P. Murtha, Alan M. Peaceman, Dinesh M. Shah, Sylvia L. Siegfried, Robert Birch |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical Publishers, Inc.
2018-04-01
|
Series: | American Journal of Perinatology Reports |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1639331 |
Similar Items
-
Discontinuation of long-established Hydroxyprogesterone Caproate; call for awareness and drug-substitutes: A Letter to the Editor
by: Muhammad Affan, et al.
Published: (2023-10-01) -
Effect of 17 α-Hydroxyprogesterone Caproate on the Prevention of Preterm Labor: A Randomized Controlled Trial Study
by: Hamed Jafarpour, et al.
Published: (2020-07-01) -
Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
by: Stephanie M. Garcia, et al.
Published: (2021-07-01) -
17-alpha hydroxyprogesterone caproate for the prevention of recurrent preterm birth among singleton pregnant women with a prior history of preterm birth: a systematic review and meta-analysis of six randomized controlled trials
by: Saeed Baradwan, et al.
Published: (2021-11-01) -
Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial
by: Joan T. Price, et al.
Published: (2019-02-01)